- Home
- About
- Partners
- Newcastle University
- University of L'Aquila
- University of Manchester
- Alacris Teranostics GmbH
- University of Pavia
- Polygene
- Consiglio Nazionale delle Ricerche
- INSERM
- Certus Technology
- Charité Universitaet Medizin
- GATC Biotech
- University Medical Center Hamburg Eppendorf
- Evercyte GmbH
- University Hospital of Cologne
- PRIMM Srl
- University of Freiburg
- University of Antwerp
- Finovatis
- Research
- SYBIL at a glance
- Bone
- Growth plate
- Desbuquois dysplasia
- Diastrophic dysplasia
- MCDS
- Osteopetrosis
- Osteoporosis
- Osteogenesis imperfecta
- Prolidase deficiency
- PSACH and MED
- Systems biology
- SOPs
- Alcian Blue staining
- Bone measurements
- BrdU labelling
- Cell counting using ImageJ
- Chondrocyte extraction
- Cre genotyping protocol
- DMMB assay for sulphated proteoglycans
- Densitometry using ImageJ
- Double immunofluorescence
- Electron microscopy of cartilage - sample prep
- Extracting DNA for genotyping
- Grip strength measurement
- Histomorphometry on unon-decalcified bone samples
- Immunocytochemistry
- Immunofluorescence
- Immunohistochemistry
- Quantitative X-ray imaging on bones using Faxitron and ImageJ
- Skeletal preps
- TUNEL assay (Dead End Fluorimetric Kit, Promega)
- Toluidine Blue staining
- Toluidine Blue staining
- Von Kossa Gieson staining
- Wax embedding of cartilage tissue
- Contact Us
- News & Events
- Links
- Portal
Finovatis
FINOVATIS SAS is a French independent consulting company (SME) based in Lyon and created in 2005. FINOVATIS is specialised in the funding, management and promotion of national and international research projects and networks. Annual turnover in June 2012: M€ 1,25. FINOVATIS combines process- and project-based approaches to fully meet our clients’ needs and satisfaction. Our customers’ satisfaction, a key indicator of our operational performance, is measured during and after project completion to help us continuously improve and offer the solutions and services best adapted to your needs. FINOVATIS provides complementary expertise (managerial, financial, fiscal, economic, technical and scientific) to assist industrialists, SMEs, universities, research institutes and associations on a long-term basis and to meet their expectations. FINOVATIS relies on a team of experienced consultants with recognised in the funding tools and management of research projects and networks at national and international levels.
Finovatis roles in SYBIL
FINOVATIS will assist the coordinator in all administrative, financial and managerial work.
Finovatis staff involved in SYBIL
Dr. David Koubi – co-founder and Chief Executive Officer. PhD in Neuropharmacology (8 international scientific publications, 2 book chapters, invited for 2 conferences (USA and France), over 10 international meetings). He headed for 4 years the European Department of a Consulting company and joined FINOVATIS in February 2008. He has managed several European projects of which TREAT-NMD (036825), THERADPOX (018700), EUMAPP (018672), BACULOGENES (037541) and is since November 2010 managing the CELL-PID FP7 project (261387) and more recently RD-CONNECT (305444), SYSCLAD (305457) and Net4CGD (305011)..
Mrs. Marie-France Bragagnolo – experienced EU Project assistant.
Dr Elodie Noël – consultant in European Projects